Provider review
MEDVi reviewed
MEDVi scores 57.4 out of 100 on our published formula for tirzepatide, ranking 15 of 24 compounded programs. It charges $399 a month all-in at 10 mg/week, and holds that price at every dose.
What it wins
No computed category, at this build. The cheapest all-in tirzepatide program is NexLife at $169.
Where it sits on tirzepatide
MEDVi is number 21 of 27 rankable tirzepatide programs on all-in monthly cost, at $399. The program immediately below it is Remedy Meds Official site at $399, $0 cheaper. The next one up is Direct Meds Official site at $399.
$0 a year separates them. What does MEDVi disclose that Remedy Meds does not? Neither names its compounding pharmacy, so the premium is not buying disclosure. Full head-to-head.
MEDVi charges a flat $399 per month for tirzepatide at every dose from 2.5 to 15 mg per week, so titrating upward does not change what you pay.
Because the rate is flat, the figure above is the figure at every rung — there is no titration surprise, and the price you are quoted on day one is the price at the top of the ladder.
| Dose | MEDVi price | Rank at this dose | Cheapest at this dose |
|---|---|---|---|
| 2.5 mg | $399 | 28 of 31 | Fifty 410 at $133 |
| 5 mg | $399 | 15 of 17 | NexLife at $169 |
| 7.5 mg | $399 | 15 of 17 | NexLife at $169 |
| 10 mg | $399 | 21 of 27 | NexLife at $169 |
| 12.5 mg | $399 | 15 of 17 | NexLife at $169 |
| 15 mg | $399 | 15 of 17 | NexLife at $169 |
Its standing is not constant across the ladder — it ranks differently at different doses, which is exactly what a single headline figure conceals.
Where it sits on semaglutide
MEDVi is number 25 of 29 rankable semaglutide programs on all-in monthly cost, at $299. The program immediately below it is Remedy Meds Official site at $299, $0 cheaper. The next one up is NovoCare Pharmacy (Wegovy) Official site at $349.
$0 a year separates them. What does MEDVi disclose that Remedy Meds does not? Neither names its compounding pharmacy, so the premium is not buying disclosure. Full head-to-head.
MEDVi charges a flat $299 per month for semaglutide at every dose from 0.25 to 2.4 mg per week, so titrating upward does not change what you pay.
Because the rate is flat, the figure above is the figure at every rung — there is no titration surprise, and the price you are quoted on day one is the price at the top of the ladder.
| Dose | MEDVi price | Rank at this dose | Cheapest at this dose |
|---|---|---|---|
| 0.25 mg | $299 | 29 of 32 | Strut Health at $99 |
| 0.5 mg | $299 | 19 of 21 | bmiMD at $129 |
| 1 mg | $299 | 19 of 21 | bmiMD at $129 |
| 1.7 mg | $299 | 19 of 21 | bmiMD at $129 |
| 2.4 mg | $299 | 25 of 29 | bmiMD at $129 |
Its standing is not constant across the ladder — it ranks differently at different doses, which is exactly what a single headline figure conceals.
What would move it
19 programs are priced below it. Reaching the top three on tirzepatide would take a price at or under $357 a month — a cut of $42 from where it stands. Alternatively, an independent checkout capture would lift its evidence component without any price change.
Why it scores what it does
Of 57.4 points, 29.6 of a possible 70 come from price measured against the $169 category floor, 12.8 of 15 from evidence status (provider-stated), 10 of 10 from dose policy and 5 of 5 from membership. Its weakest component is price against the category floor.
The evidence term is worth dwelling on. MEDVi's figure is provider-stated — taken from the provider's own published pages; checkout capture pending. An independent checkout capture would raise that component without the price changing at all, so this score is a floor rather than a ceiling.
What you are actually buying
MEDVi carries no separate membership fee, shipping included, commitment terms of Month-to-month, cancellation on Cancel before renewal.
It does not name its compounding pharmacy; the record shows Partner pharmacies, so who makes the medication cannot be verified. Availability is stated as Most US states.
Against the field
30 of 37 programs charge no membership, 8 name their pharmacy, 19 price flat. MEDVi: no membership, pharmacy unnamed, flat pricing.
What to establish before enrolling
Drawn from what this specific record does not contain:
- Whether a twelve-month tirzepatide rate exists and what it is.
- Whether a twelve-month semaglutide rate exists and what it is.
- Which compounding pharmacy fills the prescription, in writing.
- Whether the program is licensed to ship to your state.
In writing, before you pay.
On the record: Start-vs-maintenance spread on semaglutide; compare on maintenance.
Who should pick it, and who should not
Consider MEDVi if you expect to titrate to a high dose and want the price fixed before you start; you want to be able to pause without a fee continuing.
Look elsewhere if verifying who makes the medication matters to you, because the pharmacy is not named; price is your main criterion, since it runs $230 a month above the category floor.
At $399 a month it is $230 above the cheapest on record — $2,760 a year for what it discloses and includes.
Questions
Is MEDVi worth it?
At $399 a month all-in it scores 57.4 out of 100 on our published formula, against a category floor of $169. Whether that is worth it depends on whether its dose policy, pharmacy disclosure and cancellation terms justify the gap — the review above lays out both sides.
How much does MEDVi cost in total?
$399 a month all-in at 10 mg/week, or $4,788 across twelve months billed monthly. All-in means the medication plus every mandatory recurring fee.
What is cheaper than MEDVi?
Remedy Meds at $399 a month is the next cheapest tirzepatide program on record, $0 less per month. MEDVi ranks 21 of 27 on price.
Is MEDVi legitimate?
This site takes no position on any company's legitimacy. What we can report is that MEDVi does not publicly name its compounding pharmacy, so its licensing and inspection history cannot be checked independently. That is a disclosure gap, not a finding of wrongdoing.
How do I cancel MEDVi?
Cancel before renewal
Figures from the MEDVi record, dataset v2026-08-11. MEDVi official site. Prices change; verify at checkout. Compounded tirzepatide and semaglutide are not FDA-approved products.